Whereas tumor volume measurements in Mel006 bearing mice showed that dabrafenib treatment combined with TVB-3664 resulted in a non-significant volume decrease during the course of the study, Ki67 staining of Mel006 tumors revealed that BRAF inhibition combined with FASN inhibition reduces tumor cell proliferation (Fig. 2f). This evidence concerns the gene BRAF and neoplasm.